APLM Rentabilitas reged Apollomics, Inc.

Simbol resmi perusahaan Apollomics, Inc. (APLM)

Apollomics, Inc. (APLM) maintains stable management that is successfully advancing oncology programs by leveraging obtained orphan statuses. The company is developing a personalized treatment system for lung and liver tumors. The gross margin share of revenue illustrates cost efficiency, with the latest figure standing at 0.00. This confirms the strategy for the global expansion of webreltinib's presence in the Chinese and US markets to capture new segments.

Rentabilitas reged: Apollomics Corp (APLM) kanggo 21.02.2024 - 19.11.2026

Rincian metrik keuangan lan pasar Apollomics Corp (APLM)

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:APLM - Apollomics
Produk seri Apollomics Inc.

Apollomics, Inc. generates current cash flow through partnerships as it prepares to bring its own oncology drugs to market. The gross margin quantifies the efficiency of this model by measuring the portion of revenue remaining after direct production costs, allowing investors to assess the fundamental profitability of each product unit through gross profit margin dynamics.

Pesaing wigati

Margin bathi reged BeiGene Ltd. (ONC)|Tingkat bathi miturut bathi reged HALO|Rentabilitas reged RVMD|Tingkat bathi miturut bathi reged AAPG (Ascentage)|Tingkat bathi miturut bathi reged cgoncology.com CGON|UroGen Pharma - Tingkat bathi miturut bathi reged|Tingkat bathi reged BCAX|PSNL - Rentabilitas reged|Rentabilitas dodolan miturut bathi reged Erasca Oncology ERAS|delcath.com (DCTH) - Rentabilitas reged|Y-mAbs Therapeutics - Tingkat bathi reged|AURA (Aura Biosciences Inc) - Margin reged|Margin bathi reged candeltx.com CADL|Margin reged ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Tingkat bathi reged|Rentabilitas reged Actuate Therapeutics, Inc. ACTU|citiusonc.com - Rentabilitas reged|TuHURA Biosciences Inc. - Margin reged|TARA - Margin reged|FATE (Fate Therapeutics) - Tingkat bathi miturut bathi reged|Tingkat bathi miturut bathi reged Aadi Bioscience, Inc.|Tingkat bathi miturut bathi reged TCRX|Rentabilitas reged CSBR|Margin reged XBIT|Rentabilitas dodolan miturut bathi reged CEL-SCI Corp.|Rentabilitas reged ostherapies.com OSTX|RADX: Rentabilitas dodolan reged|ARTV: Tingkat bathi miturut bathi reged|ANL (Adlai Nortye) - Rentabilitas dodolan reged|Veru (VERU) - Rentabilitas reged|Tingkat bathi miturut bathi reged Tempest Therapeutics Inc|Rentabilitas reged Xilio Therapeutics|Rentabilitas dodolan reged RENB (Renovaro Inc.)|Rentabilitas reged Mural Oncology PLC (MURA)|Margin reged Kairos Pharma (KAPA)|Rentabilitas reged onkuretherapeutics.com OKUR|GDTC: Rentabilitas dodolan reged|CRIS: Tingkat bathi miturut bathi reged|Tharimmune Corp (THAR) - Tingkat bathi miturut bathi reged|ADVB: Margin reged|Tingkat bathi miturut bathi reged Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Margin reged|Rentabilitas dodolan reged SBFM (Sunshine Biopharma)|Rentabilitas reged Xenetic Bio (XBIO)|Rentabilitas reged SLRX (Salarius Pharma)|Kitov Pharma - Tingkat bathi miturut bathi reged|American Oncology Network (AONC) - Margin bathi reged|BeiGene - Margin reged|Checkpoint Therapeutics, Inc. (CKPT) - Tingkat bathi miturut bathi reged|ELEV (Elevation Oncology, Inc.) - Tingkat bathi miturut bathi reged|iCAD Inc. - Tingkat bathi reged|Tingkat bathi miturut bathi reged IKNA|Margin reged notablelabs.com|Tingkat bathi miturut bathi reged VIRX (Viracta Therapeutics Inc.)|MOR - Margin bathi reged|Rentabilitas reged NAYA Biosciences NAYA|AAPGV - Tingkat bathi miturut bathi reged